2018
DOI: 10.1016/j.lfs.2018.05.031
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of antioxidant potencial of novel CaAl and NiAl layered double hydroxides loaded with olanzapine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 45 publications
0
5
0
Order By: Relevance
“…Olanzapine (OLZ), 2-methyl-4-(4-methyle-1piperazinyl)-10H-thieno(2,3b)(1,5) benzodiazepine (37,38), is a second-generation atypical antipsychotic drug approved by the Food and Drug Administration (FDA) as a first-line therapy for the treatment of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia (39)(40)(41)(42)(43). Schizophrenia is a severe and chronic psychotic disorder, considered the most disabling psychiatric disorders with enormous economic and social impact (44).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Olanzapine (OLZ), 2-methyl-4-(4-methyle-1piperazinyl)-10H-thieno(2,3b)(1,5) benzodiazepine (37,38), is a second-generation atypical antipsychotic drug approved by the Food and Drug Administration (FDA) as a first-line therapy for the treatment of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia (39)(40)(41)(42)(43). Schizophrenia is a severe and chronic psychotic disorder, considered the most disabling psychiatric disorders with enormous economic and social impact (44).…”
Section: Introductionmentioning
confidence: 99%
“…OLZ is known to bind and antagonize copious receptors such as dopamine (D1, D2, D3, and D4); 5HT2 a , 5HT2 c , 5HT3, and 5HT6; histamine at H1 receptors; and alpha-1 adrenergic receptors (38,45,46) . Despite its vast applications in psychotic disorders, OLZ have an issue of poor water solubility that leads to unreliable absorption and erratic pharmacokinetic profiles (41,47). Therefore, the need to develop appropriate drug delivery system for efficient schizophrenia therapy is vital.…”
Section: Introductionmentioning
confidence: 99%
“…These processes result in an increase in oxidative, nitrosative, and sulfuric damage, which may include impaired glucose metabolism and the associated loss of ion gradients depending on functional potential disturbances and Ca 2+ transport [144]. During oxidative stress, there is an intracellular increase in free Ca 2+ levels, which are known to have unfavorable consequences, including depolarization of mitochondrial membranes, oxidative phosphorylation disorders, and overproduction of free radicals.…”
Section: Oxidative Nitrosative and Sulfuric Stress In Schizophreniamentioning
confidence: 99%
“…55% maximum effect, which is very similar, if not slightly higher than bare Irganox 1425. The LDH hybrid of olanzapine (2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno [2,3-b] [1,5]-benzodiazepine) was also developed to overcompensate its low water solubility [123]. This drug molecule is a popular antipsychotic agent and due to the correlation between oxidative stress and brain damage [168], its antioxidant potential may be a reason for its pharmaceutical efficacy.…”
Section: Layered Double Hydroxides (Ldhs)mentioning
confidence: 99%